Retinoblastoma patients with high risk ocular pathological features: Who needs adjuvant therapy?

British Journal of Ophthalmology

Volumn 88, Issue 8, 2004, Pages 1069-1073

  Chantada, G L ^a   Dunkel, I J ^b   De Davila M T G ^c   Abramson, D H ^d  

^a HOSPITAL DE PEDIATRÍA PROF DR JUAN P GARRAHAN   (Argentina)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c Department of Pathology   (Argentina)

^d NY Presbyterion Hosp: Weill Cornell ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ADJUVANT DISEASE; ADJUVANT THERAPY; ADULT; ANTERIOR EYE CHAMBER; ARTICLE; CANCER INVASION; CHOROID; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; OPTIC NERVE; PRIORITY JOURNAL; RECURRENCE RISK; RECURRENT DISEASE; RETINOBLASTOMA; RISK ASSESSMENT; RISK FACTOR; SCLERA; SCLERA DISEASE;

ANTERIOR CHAMBER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHILD; CHILD, PRESCHOOL; CHOROID NEOPLASMS; COMBINED MODALITY THERAPY; EYE ENUCLEATION; FEMALE; HUMANS; INFANT; MALE; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; OPTIC NERVE NEOPLASMS; RETINAL NEOPLASMS; RETINOBLASTOMA; RETROSPECTIVE STUDIES; RISK FACTORS; SCLERAL DISEASES; TREATMENT OUTCOME;

EID: 3543045618     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.2003.037044     Document Type: Article

References (16)

1. Khelfaoui F, Validre P, Auperin A, et al. Histopothologic risk factors in retinoblastoma. A retrospective study of 172 patients treated in a single institution. Cancer 1996;77:1206-13.
2. Uusitalo M, Van Quill K, Scott I, et al. Evaluation of chemoprophylaxis in patients with unilateral retinoblastoma with high-risk features on histopathologic examination. Arch Ophthalmol 2001;119:41-8.
3. Honavar G, Singh A, Shields C, et al. Post enucleation adjuvant therapy in high risk retinoblastoma. Arch Ophthalmol 2002;120:923-31.
4. Magramm I, Abramson D, Ellsworth R. Optic nerve involvement in retinoblastoma. Ophthalmology 1989;96:217-22.
5. Stannard C, Sealy L, Sevel D. Retinoblastoma: Correlation of invasion of the optic nerve and choroid with prognosis and metastases. Br J Ophthalmol 1979;63:560-70.
6. Schvartzman E, Chantada G, Fandiño A, et al. Results of a stage-based protocol for the treatment of retinoblastoma. J Clin Oncol 1996;14:1532-6.
7. Dunkel U, Aledo A, Kernan NA, et al. Successful treatment of metastatic retinoblastoma. Cancer 2000;89:2117-21.
8. Namouni F, Doz F, Tanguy ML, et al. High dose chemotherapy with carboplatin, etoposide and cyclophosphamide followed by hematopoietic stem cell rescue in patients with high risk retinoblastoma: a SFOP and SFGM study. Eur J Cancer 1997;33:2368-75.
9. Chantada G, Fandiño A, Casak S, et al. Treatment of overt extraocular retinoblastoma. Med Pediatr Oncol 2003:40:158-61.
10. Grabowski E, Abramson D. Intraocular and extraocular retinoblastoma. Hematol Oncol Clin North Am 1987;1:721-35.
11. Doz F, Neuenshwander S, Plantaz D, et al. Etoposide and carboplatin in extraocular retinoblastoma: A study by the Société Française d'Oncologie Pédiatrique. J Clin Oncol 1995;13:902-9.
12. Chantada G, Fandiño A, Mato G, et al. A phase II window of Idarubicin in children with extraocular retinoblastoma. J Clin Oncol 1999;17: 1847-50.
13. Chantada GL, de Davila MT, Fandiño A, et al. Retinoblastoma with low risk for extraocular relapse. Ophtalmic Genet 1999;20:133-40.
14. Shields C, Shields J, Baez K, et al. Choroidal invasion of retinoblastoma:metastatic potential and clinical risk factors. Br J Ophthalmol 1993;77:544-8.
15. Messmer E, Heinrich T, Hopping W, et al. Risk factors for metastases in patients with retinoblastoma. Ophthalmology 1991;98:136-41.
16. Shields C, Shields J, Baez K, et al. Optic nerve invasion of retinoblastoma. Metastatic potential and clinical risk factors. Cancer 1994;73:692-8.